VCAM1 and cancer: β1 integrins also participate in cancer cell attachment to mesothelial monolayers [33, 37–39], which could reflect that cancer cells are binding to the mesothelium-associated ECM and/or to mesothelial cell surface VCAM-1, as outlined above.